These final results, together with a previous report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 aid the principle of targeting ACKR3 as a singular method to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-linked Diseases.We independently research, evaluatio